Updated GB 27952 Standard for General Disinfectants in 2026

Since its implementation on November 1, 2020, GB 27952-2020 – General Requirements for Surface Disinfectants has been the mandatory national standard for disinfectants intended for use on general object surfaces in China. As of 2026, with full enforcement of WS 628-2018 (Hygienic Safety Evaluation Technical Requirements for Disinfectants), Chinese customs and health authorities have significantly intensified inspections. Non‑compliant products face detention, fines, or market withdrawal. Understanding and strictly implementing GB 27952-2020 is now essential for disinfectant manufacturers, importers, and end‑users across hospitals, schools, public facilities, and households. This guide provides a comprehensive overview of the standard’s scope, technical requirements, testing protocols, and compliance roadmap.

1. Scope and Application

GB 27952-2020 applies to all disinfectants used on general object surfaces – defined as surfaces of articles, instruments, equipment, and facilities (including walls and floors) in medical institutions, schools, public places, and homes. A key change from the 2011 version is the removal of the term “preventive disinfection”. The 2020 edition covers all types of disinfection – including outbreak site disinfection, healthcare infection control, and routine preventive disinfection. Regardless of the use scenario, any disinfectant marketed for general surface disinfection must comply fully with this standard.

2. Raw Material Quality Control

GB 27952-2020 establishes strict raw material requirements by referencing specific chemical disinfectant standards:

  • Chlorine-based disinfectants (sodium hypochlorite, calcium hypochlorite) – must comply with “Hygienic Quality Technical Specifications for Sodium Hypochlorite Disinfectants” and relevant specifications for bleaching powder.
  • Bromine-based disinfectants – GB/T 26370.
  • Peroxide disinfectants (peracetic acid, hydrogen peroxide) – GB/T 26371.
  • Chlorine dioxide disinfectants – GB/T 26366.
  • Alcohol disinfectants (ethanol, isopropanol) – GB/T 26373.
  • Phenolic disinfectants – GB/T 27947.
  • Quaternary ammonium disinfectants – GB/T 26369.
  • Guanidine disinfectants – GB/T 26367.
  • Other types (iodophors, glutaraldehyde, electrolyzed oxidizing water) must meet corresponding national or industry standards.
  • Production water must comply with the “Hygienic Specifications for Disinfectant Production Enterprises” (2009 edition).

Importers should request certificates of analysis (COA) from raw material suppliers verifying compliance with these referenced standards.

3. Key Technical Requirements

3.1 Physicochemical Indicators

  • Active ingredient concentration: Must remain within ±10% of the labelled nominal value (unless otherwise specified by national standards).
  • pH value: Must stay within ±1 of the labelled nominal value.
  • Heavy metals: Lead, mercury, arsenic must comply with “Safety and Technical Standards for Cosmetics” or relevant industry limits.

3.2 Stability

During the labelled shelf life, the active ingredient degradation rate must not exceed 10%, and the remaining concentration must remain within the labelled specification range. Stability testing must be performed according to standard methods. Chlorine-based disinfectants require clear storage instructions (away from light, sealed) to prevent premature degradation.

3.3 Microbiological Efficacy

Disinfectants must demonstrate the following log reductions:

  • E. coli and S. aureus: Suspension quantitative test ≥5.00 log reduction; carrier quantitative test ≥3.00 log reduction.
  • Simulated field test: ≥3.00 log reduction.
  • Field test (natural flora): ≥1.00 log reduction.

If the product claims efficacy against any microorganism beyond the standard’s required test strains (E. coli, S. aureus), or if it claims activity against other specific pathogens, a test report from a qualified third‑party laboratory is mandatory – a requirement introduced in the 2020 edition.

3.4 Toxicological Safety

  • Acute oral toxicity: The undiluted product or a 5× dilution of the highest use concentration must be classified as “practically non‑toxic”.
  • Mutagenicity: Must be negative in appropriate genotoxicity tests.
  • Skin irritation: Must be rated as “no irritation” or “mild irritation”.

3.5 Metal Corrosion – New Requirement (2020 Edition)

At the in‑use concentration, corrosion to metals must be rated as “mild corrosion” or lower, with no structural damage to the metal substrate. This is especially important for disinfectants used on medical devices, food processing equipment, or other metal surfaces.

4. Application Methods and Appendix Recommendations

GB 27952-2020 specifies five authorized application methods:

  • Wiping
  • Soaking
  • Spraying / atomizing
  • Vaporization (new in 2020)
  • Flow rinsing (new in 2020)

Fumigation is not included due to lack of recent evidence supporting its efficacy. Appendix A provides detailed recommendations for each disinfectant type. Two notable changes from the 2011 edition:

  • For chlorine‑based disinfectants under contaminated conditions, the recommended active concentration range has been increased from 400‑500 mg/L to 400‑700 mg/L (aligned with WS/T 512-2016).
  • Contact time: Adjusted to 10‑30 minutes (previously the lower bound was 30 minutes). Recognizing that during wiping, the disinfectant often dries out, the 10‑minute minimum makes the standard more practical for frontline use.

5. Disinfectant Filing and Hygienic Safety Evaluation

GB 27952-2020 is enforced through the hygienic safety evaluation and filing system under WS 628-2018. Before a disinfectant product can be sold or imported into China, the manufacturer or its China agent must complete a hygienic safety evaluation and submit the filing to the National Disinfectant Online Filing Information Platform. Required documents include:

  • Filing cover sheet
  • Product label and instructions (compliant with GB 38598-2020)
  • Complete formulation and manufacturing process
  • Product specifications (technical requirements)
  • Manufacturer‘s or contract manufacturer’s “Disinfectant Production Enterprise Hygiene License”
  • Entrustment agreement (if applicable)
  • Test reports: microbiological efficacy, toxicology, stability, metal corrosion (as applicable)

Disinfectants are classified into Category I (high‑level disinfection for medical devices, skin/mucous membrane disinfectants) and Category II (general surface disinfectants). All required tests must be performed by laboratories with CNAS accreditation and recognized by the filing authority.

6. Compliance Roadmap for Importers and Manufacturers

As of 2026, Chinese customs and health inspectors are strictly verifying that imported disinfectants have a valid filing record on the national platform. Any discrepancy between the product label, technical documentation, and the filed information can lead to detention, return, or destruction. To ensure smooth market access:

  1. Verify classification: Confirm that your product falls under the scope of GB 27952-2020 (general surface disinfection) and not under more stringent categories (e.g., high‑level disinfectants).
  2. Engage a CNAS‑accredited lab: Conduct all required tests – active ingredient content, stability, microbiological efficacy (including any additional claims), toxicology, and metal corrosion (where applicable). Ensure test reports are issued within the last 3 years.
  3. Prepare a complete filing dossier: Use the templates provided by the filing platform. Ensure all documents are in simplified Chinese or accompanied by certified translations.
  4. Appoint a China agent: Foreign manufacturers must appoint a local responsible party (agent) to submit the filing and act as the legal contact.
  5. Submit online: Upload the dossier to the National Disinfectant Online Filing Information Platform. The filing typically takes 2‑4 weeks for review.
  6. Label compliance: Ensure the product label includes the filing number, active ingredient(s) and concentration, use instructions, contact time (10‑30 minutes), storage conditions, and the standard number GB 27952-2020. Include the mandatory child safety warnings where applicable.

7. Common Rejection Reasons and How to Avoid Them

Based on recent filing rejections, avoid these common mistakes:

  • Missing efficacy data for claimed additional microorganisms: If the label claims effectiveness against viruses, fungi, or specific bacteria beyond E. coli/S. aureus, test reports for those organisms must be included. General references to “broad‑spectrum” without data are rejected.
  • Incorrect contact time: The label must specify a contact time between 10 and 30 minutes (or longer if supported by data). Times shorter than 10 minutes are not permitted.
  • Metal corrosion test omitted for metal‑surface disinfectants: If the product is intended for use on metal objects (e.g., medical instruments, food equipment), a corrosion test report is mandatory.
  • Stability test not covering the claimed shelf life: The stability report must cover the entire claimed shelf life (e.g., 24 months). Accelerated stability data may be accepted but must follow standard protocols.
  • No agent POA or expired POA: The power of attorney for the China agent must be notarized, legalized (or apostilled), and accompanied by a certified Chinese translation. Ensure it is current.
🚀 Need help with GB 27952 compliance or disinfectant filing? Contact a China disinfectant regulatory partner for a free compliance assessment. Our experts will review your product formulation, test reports, and labeling – and manage the entire filing process. Request your free consultation today.

Summary: GB 27952-2020 sets the mandatory requirements for general surface disinfectants in China, covering active ingredient stability, microbiicidal efficacy (≥5.00 log reduction for bacteria), toxicological safety, metal corrosion (new in 2020), and five authorized application methods. Full enforcement in 2026 requires disinfectant importers to complete a hygienic safety evaluation and filing under WS 628-2018, with all test reports from CNAS‑accredited labs. Compliance ensures not only legal market access but also effective protection of public health. Start your filing preparation early – attention to detail in stability testing, efficacy claims, and labeling will prevent costly rejections.